James L. Tyree, Director at ChemoCentryx, Inc. (CCXI), sold 2,454 shares at $9.76 ($24K) on 2021-05-21, disclosed to the SEC on 2021-05-24.
Scheduled sale ($24k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ASRT | SELL | 2024-03-15 | $11K | — | Filing → |
| GNLX | SELL | 2023-12-14 | $192K | — | Filing → |
| ASRT | SELL | 2023-05-05 | $259K | — | Filing → |